Columbia Sportswear Company Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments And Risk Management (Tables)

6 Months Ended

Jun. 30, 2014

The following table presents the gross notional amount of outstanding derivative instruments (in thousands):



	June 30, 2014		December 31, 2013		June 30, 2013
Derivative instruments designated as cash flow hedges:
Currency forward contracts	$	127,000	$	99,000	$	71,500
Derivative instruments not designated as cash flow hedges:
Currency forward contracts	63,500		109,000		77,000

The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):



	Balance Sheet Classification	June 30, 2014		December 31, 2013		June 30, 2013
Derivative instruments designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	$	986	$	1,936	$	2,516
Currency forward contracts	Other non-current assets	155		24		343
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	1,081		872		262
Currency forward contracts	Other long-term liabilities	12		95		—
Derivative instruments not designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	302		2,956		1,855
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	650		280		460

The following table presents the statement of operations effect and classification of derivative instruments (in thousands):



	Statement of Operations Classification	Three Months Ended June 30,						Six Months Ended June 30,
	Statement of Operations Classification	2014			2013			2014			2013
Currency Forward Contracts:
Derivative instruments designated as cash flow hedges:
Gain (loss) recognized in other comprehensive income or loss	—	$	(634	)	$	727		$	70		$	2,880
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Cost of sales	690			766			1,499			1,626
Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Cost of sales	(186		)	(2		)	(208		)	(45		)
Derivative instruments not designated as cash flow hedges:
Gain (loss) recognized in income	Other non-operating expense	(506		)	2,663			(1,971		)	6,012